SVB’s collapse is a reminder of how far IP finance still has to travel
Like many others, the bank held thousands of patents as security for loan deals, but almost certainly had no idea of their value – or lack of it
Like many others, the bank held thousands of patents as security for loan deals, but almost certainly had no idea of their value – or lack of it
Marconi's Kasim Alfalahi takes the top spot for Avanci's stellar showing in our countdown of the patent market’s most innovative and influential dealmakers and decision takers
We compiled data from Westfleet Advisors’ annual litigation funding reports to find patent finance shot up by nearly 50% since 2020 – to the benefit of rights holders
The world’s pre-eminent event focusing on IP value creation takes place in Chicago from 12 to 14 June with over 500 senior delegates set to attend
19 May 2022
Analysis from Stout suggests rates sought by certain Enhanced Voice Services (EVS) patent owners are out of line with the overall 3G/4G/5G FRAND landscape
18 May 2022
Terran Biosciences has emerged from obscurity to snap up slew of IP rights in the past two months
04 May 2022
Patent litigators who represent plaintiffs and defendants agree the new standing order favours the defence, but one litigation financier predicts well-financed patentees backed by reputable lenders will get the upper hand
29 April 2022
The latest wireless standard hasn’t yet found its ‘killer app’ for consumers, and it’s affecting licensing negotiations
23 April 2022
Patent brokers and litigation financiers say that over the past year there is a growing trend of lawsuit funders exploring the idea of acquiring their own patent portfolios for monetisation through licensing or litigation
20 April 2022
Hedonic regression is a dependable and impartial way to estimate the value of a standardised technology. Further, it can be applied to a range of products, especially those with multiple features.
13 April 2022
Following major US CRISPR decision, Michael Arciero, VP of IP at ERS Genomics, tells IAM that tricky patent landscapes are the new normal in biotech
04 April 2022
Returning from two action-packed days in London, IAM Deputy Editor Adam Houldsworth reflects on the surprising state of corporate UPC strategies, the rise of AI, FRAND fireworks and more
02 April 2022
Patent value, IP finance and the challenges of digitisation were just some of the subjects discussed in front of a sell-out audience in London yesterday
31 March 2022
Unlock unlimited access to all IAM content